AVDL vs. ARRY

Last updated Jun 4, 2026

AVDL (Avadel Pharmaceuticals plc) and ARRY (Array Technologies, Inc.) are both stocks. AVDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while ARRY operates in Solar (Technology). At a 0.16 correlation, their price movements are largely independent.

Performance

AVDL vs. ARRY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avadel Pharmaceuticals plc (AVDL) and Array Technologies, Inc. (ARRY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

AVDL

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ARRY

• 1D: -5.10%
• 1M: 14.23%
• YTD: -5.10%
• 6M: 12.32%
• 1Y: 24.82%
• 3Y*: -28.32%
• 5Y*: -10.26%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AVDL vs. ARRY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
AVDL Avadel Pharmaceuticals plc	0.42%	105.04%	-25.57%	97.21%	-11.39%	20.96%	22.79%
ARRY Array Technologies, Inc.	-5.10%	52.65%	-64.05%	-13.09%	23.20%	-63.63%	18.35%

Correlation

The correlation between AVDL and ARRY is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Oct 16, 2020	0.16

Fundamentals

Market Cap AVDL : $2.19B ARRY : $1.34B
EPS AVDL : -$0.00 ARRY : -$0.44
PS Ratio AVDL : 8.72 ARRY : 1.11
Total Revenue (TTM) AVDL : $248.52M ARRY : $1.21B
Gross Profit (TTM) AVDL : $234.76M ARRY : $269.92M
EBITDA (TTM) AVDL : $10.13M ARRY : $5.35M

Return for Risk

AVDL vs. ARRY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARRY

ARRY Risk / Return Rank: 53
ARRY Sharpe Ratio Rank: 51
ARRY Sortino Ratio Rank: 53
ARRY Omega Ratio Rank: 53
ARRY Calmar Ratio Rank: 53
ARRY Martin Ratio Rank: 53

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVDL vs. ARRY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avadel Pharmaceuticals plc (AVDL) and Array Technologies, Inc. (ARRY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	AVDL	ARRY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.30	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.13	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.27	—

Drawdowns

Drawdown Indicators

	AVDL	ARRY	Difference
Max Drawdown Largest peak-to-trough decline	—	-92.20%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-44.31%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-84.88%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-85.31%	—
Current Drawdown Current decline from peak	—	-82.86%	—
Average Drawdown Average peak-to-trough decline	—	-68.87%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	22.49%	—

Volatility

Volatility by Period

	AVDL	ARRY	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	19.62%	—
Volatility (6M) Calculated over the trailing 6-month period	—	61.63%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	83.53%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	81.32%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	82.04%	—

Dividends

AVDL vs. ARRY - Dividend Comparison

Neither AVDL nor ARRY has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both AVDL and ARRY in my portfolio?

AVDL and ARRY have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.